Literature DB >> 8986282

Lethal multiple pterygium syndrome: suggestion for a consistent pathological workup and review of reported cases.

U G Froster1, T Stallmach, J Wisser, G Hebisch, M B Robbiani, R Huch, A Huch.   

Abstract

We report on 2 brothers with lethal multiple pterygium syndrome (LMPS) born to non-consanguineous parents as late spontaneous abortions. Both fetuses presented with massive nuchal edema, and facial anomalies including cleft palate and broad ribs. Apparently, several subgroups of LMPS exist. Differentiation is difficult, as there is no consistent agreement on a workup protocol for autopsies. We compared the findings in the literature on cases with LMPS, and we suggest a standardized workup as an initial step for more efficient differentiation between various subgroups.

Entities:  

Mesh:

Year:  1997        PMID: 8986282     DOI: 10.1002/(sici)1096-8628(19970110)68:1<82::aid-ajmg16>3.0.co;2-k

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  3 in total

1.  Mutations in the embryonal subunit of the acetylcholine receptor (CHRNG) cause lethal and Escobar variants of multiple pterygium syndrome.

Authors:  Neil V Morgan; Louise A Brueton; Phillip Cox; Marie T Greally; John Tolmie; Shanaz Pasha; Irene A Aligianis; Hans van Bokhoven; Tamas Marton; Lihadh Al-Gazali; Jenny E V Morton; Christine Oley; Colin A Johnson; Richard C Trembath; Han G Brunner; Eamonn R Maher
Journal:  Am J Hum Genet       Date:  2006-06-20       Impact factor: 11.025

2.  Mutation analysis of CHRNA1, CHRNB1, CHRND, and RAPSN genes in multiple pterygium syndrome/fetal akinesia patients.

Authors:  Julie Vogt; Benjamin J Harrison; Hayley Spearman; Judy Cossins; Sascha Vermeer; Lambert Naudin ten Cate; Neil V Morgan; David Beeson; Eamonn R Maher
Journal:  Am J Hum Genet       Date:  2008-01       Impact factor: 11.025

3.  Lethal multiple pterygium syndrome, the extreme end of the RYR1 spectrum.

Authors:  Ariana Kariminejad; Siavash Ghaderi-Sohi; Hamid Hossein-Nejad Nedai; Vahid Varasteh; Ali-Reza Moslemi; Homa Tajsharghi
Journal:  BMC Musculoskelet Disord       Date:  2016-03-01       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.